Prevalence of metabolic syndrome in pre- and postmenopausal women

AUTOR(ES)

Marchi, Ricardo de, Dell’Agnolo, Cátia Millene, Lopes, Tiara Cristina Romeiro, Gravena, Angela Andréia França, Demitto, Marcela de Oliveira, Brischiliari, Sheila Cristina Rocha, Borghesan, Deise Helena Pelloso, Carvalho, Maria Dalva de Barros, Pelloso, Sandra Marisa

FONTE

Arch. Endocrinol. Metab.

DATA DE PUBLICAÇÃO

16/02/2017

RESUMO

ABSTRACT Objective The objective of this study was to determine the prevalence of metabolic syndrome (MS) and its components among pre- and postmenopausal women, as well as the association between menopausal status and MS. Materials and methods A retrospective study was conducted at a reference cardiology outpatient clinic in a city located in Northwestern Paraná State, Brazil. A total of 958 medical records of symptomatic climacteric women evaluated between 2010 and 2014 were analyzed. The study consisted of two groups: pre- and post-menopausal women. MS was characterized according to the criteria of the National Cholesterol Education Program’s Adult Treatment Panel III – NCEP-ATP III-2005. Results MS was observed in 18.5% of the total study population; 9.4% of the premenopausal women and 22.2% of the postmenopausal women displayed MS, corresponding to a relative risk of 2.75. In addition, the frequency of MS increased with age. Regarding the components of MS, postmenopausal women were more likely to have high density lipoprotein (HDL-C) levels < 50 mg/dL; systolic blood pressure (SBP) values ≥ 130 mmHg or diastolic blood pressure (DBP) values ≥ 85 mmHg; and fasting glucose levels ≥ 100 mg/dL. Conclusion MS was more prevalent among postmenopausal women than among premenopausal women.

Documentos Relacionados

• Metabolic clearance and production rates of human luteinizing hormone in pre- and postmenopausal women
• Metabolic syndrome and sexual function in postmenopausal women
• Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies
• TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy
• Association between handgrip strength and body composition, physical fitness, and biomarkers in postmenopausal women with metabolic syndrome